Compliance Perspectives: The 12 Things to Include in Your Drug & Alcohol Testing Policy

MYTH Employee drug testing is illegal in states where it's legal to use recreational or medical marijuana WHAT'S AT STAKE No! No! No! The truth is that state laws on marijuana use and … [Read more...]


PAMA Reimbursement: CMS Tells Labs How to Secure ADLT Status for New Tests

Although the 2018 market-based Clinical Laboratory Fee Schedule (CLFS) is officially in effect, implementation of the new PAMA Part B payment rules for lab tests remains a work in progress. On March … [Read more...]


Compliance Perspectives: New Stark Rules Offer Some Physician Kickback Relief but Not Nearly Enough

As a lab compliance officer, you have better things to do with your time than read government budget bills. But what you do need to know is that the new federal Bipartisan Budget Act of 2018 includes … [Read more...]


Compliance Perspectives: Avoid Privacy Pitfalls in Pandemic Planning & Response

Although not officially a pandemic, the 2018 flu season has been the worst in nearly a decade. So why not use it as an opportunity to review your lab's pandemic preparations—or, if you haven't already … [Read more...]


Compliance Perspectives: Can You Require Lab Workers to Get a Flu Shot?

Bottom Line on Top: Yes, a mandatory flu vaccination policy is legally justifiable as long as: You can show that vaccination is a necessary health and safety measure; The policy doesn't … [Read more...]


5 Common Sexual Harassment Policy Blind Spots & How to Fix Them

Recent weeks have witnessed the morphing of workplace sexual harassment prevention from legal requirement to moral imperative. And while the current fervor is a bit unnerving for employers, to the … [Read more...]


The 10 Assumptions NOT to Make when Doing Your OSHA 300s

December is here and it's time for the logs. No, not the yule logs—the OSHA 300 logs! It's time to get the year's injury and illness records in order and start getting the OSHA 300A ready for the Feb. … [Read more...]


CMS Finalizes Controversial PAMA Fee Schedule

It's official. Brushing aside fierce lab industry opposition, CMS has decided to go forward with its PAMA Clinical Laboratory Fee Schedule (CLFS) in 2018. The Flawed Fee Schedule The intent of the … [Read more...]


PAMA-Geddon: Proposed 2018 Lab Pay Rates Are a Bloodbath

There will be no delay; and And hospital labs will remain excluded from "applicable laboratories" on which supposed market rate payments for lab tests will be based. Those were the first … [Read more...]

Compliance Perspectives: Private Sector Joins the Battle against Lab Fraud

The crackdown on lab fraud has been going on for decades. But now the dynamics are changing. While federal prosecutors and private whistleblowers continue to supply most of the impetus, they have been … [Read more...]